Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

6 Jun 2024 07:00

RNS Number : 3086R
Camellia PLC
06 June 2024
 

6 June 2024

Camellia Plc

(the "Company" or the "Group")

 

Trading update

 

 

 

Tea

India: Production in May in all regions has been severely affected by very dry weather which is also expected to impact yields in June. While there are some early signs that prices for Assam and Darjeeling teas may be improving, it is too early in the season to adjust our forecasts. In the face of a substantial tightening of regulations around the use of chemicals in the growing process, the India subsidiary companies have decided to materially reduce bought leaf production as a risk mitigation strategy.

 

Bangladesh: Following industry discussions with the Bangladesh Tea Board, a fair pricing mechanism is being developed with the objective of improving prices and margins for producers. Other initiatives to support the industry, are also under consideration by government. While these are positive developments they are at an early stage and the scale of impact is not clear. 

 

Kenya: Favourable weather meant crops in May were higher than expected. However, as mentioned in our annual report, significant stocks of tea have been building up in the Kenya industry over recent years. With the revised minimum pricing mechanism, these are now being released to the market for sale with a significantly bigger impact on tea prices in the last month than expected. It looks like these lower prices are likely to continue for the remainder of this year. There is no obvious catalyst for prices to improve and in fact they may further weaken. Estimating the scale of this and hence the impact on our prices is difficult at this early stage in the year. The strength of the Kenya shilling remains a headwind.

 

Malawi: Weaker prices in Kenya have also impacted Malawi tea demand with further softening of prices in this market too. Production volumes in Malawi remain in line with expectations. 

 

Other crops

Other crops are performing in line with the guidance previously given.

 

BF&M

As mentioned in the annual report, the disposal of our interest in BF&M to Argus Group has been more complex and the approval process more protracted than expected. While we are still confident the sale of our stake will go ahead, further delays in the regulatory approval process mean we now expect completion in the latter part of 2024. The sale of BF&M is expected to result in cash consideration of $100m payable to Camellia, before expenses.

 

Bardsley

Progress has been made in the closure of the Bardsley's operation. We have now exited the two major leases and negotiations with the remaining landlords are ongoing. Asset disposals are also underway and we are on track to conclude the winding up process before the end of the year.

 

We expect to report a reduced loss for the year from Bardsley in the range of £3.5-4.5 million (2023: Loss £15.6 million). This includes the trading loss as well as the estimated cost of exiting leases, impairments, closure costs and the results of asset disposals. We expect a net cash recovery from the closure of £4-5 million. It is expected that Bardsley will be accounted for as a 'Discontinued operation' in 2024. 

 

Outlook for the year for continuing operations

Forecasting the outcome for the year at this stage in the year is difficult, not least because the majority of our production and sales occurs in the second half of the year. That said, despite reduced tea production expectations in India and further reductions in tea prices in Kenya and Malawi we continue to expect revenue above that of 2023. However, the outlook for the adjusted loss before tax for continuing operations has worsened from our previous guidance and is now at between £10-12 million (2023: £2.5 million loss).

 

Camellia had net cash of £21.7 million and investment portfolios with a market value of £38.1 million at 31 March 2024.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Byron Coombs, CEO

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisors Maitland 

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZGGVVKKGDZM
Date   Source Headline
4th Jun 202612:31 pmRNSResult of AGM
22nd May 20267:00 amRNSSale of Chalouni Tea Estate
5th May 20267:00 amRNSFinal Results
7th Apr 20264:19 pmRNSProposed Sale of Chalouni Tea Estate
1st Apr 20267:00 amRNSArtwork Sale and Update on Indian Tea Estate MOU
23rd Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSDirectorate change
27th Nov 20257:00 amRNSKakuzi Land Claims
8th Sep 20254:47 pmRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSHalf Year Results
26th Aug 20257:00 amRNSNotice of Half Year Results
4th Jul 20254:30 pmRNSDisposal
13th Jun 20254:01 pmRNSHolding(s) in Company
13th Jun 20252:35 pmRNSHolding(s) in Company
10th Jun 20259:09 amRNSHolding(s) in Company
9th Jun 20254:39 pmRNSHolding(s) in Company 9 June 2025
6th Jun 20257:00 amRNSResult of Tender Offer
5th Jun 20252:02 pmRNSResult of General Meetings
19th May 20257:00 amRNSTender Offer
19th May 20257:00 amRNSValue Enhancement Plan
13th May 20257:00 amRNSHolding(s) in Company
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSValue Enhancement Plan Date & Presentation
30th Apr 20257:00 amRNSFinal Results
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSPotential Disposal
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20259:07 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSDisposal
11th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSPotential Disposal
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.